A Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer

Summary

This study proposed the comparison the overall survival, hematological toxicity, pain reduction score,PSA levels, tumor response, quality of life in two arms of HRPC patients from different parts of India.

Timeline

Start

2007-11

Primary completion

2013-01

Completion

2013-01

Outcome

Outcome not reported

Stopped: “Interim Analysis report indicates trial futility”

Drugs

Indications